CN Patent

CN103228280B — 包含瑞伐拉赞或其盐的可注射液体组合物

Assigned to Liu Hanyangxing · Expires 2015-11-25 · 10y expired

What this patent protects

本发明提供了一种注射用液体组合物，其利用某种表面活性剂或某种表面活性剂组合使治疗有效量的瑞伐拉赞或其盐以胶束或混合胶束的形态溶解于水介质中；一种制备所述组合物的方法；以及一种通过干燥所述注射用液体组合物而获得的注射用干粉。

USPTO Abstract

本发明提供了一种注射用液体组合物，其利用某种表面活性剂或某种表面活性剂组合使治疗有效量的瑞伐拉赞或其盐以胶束或混合胶束的形态溶解于水介质中；一种制备所述组合物的方法；以及一种通过干燥所述注射用液体组合物而获得的注射用干粉。

Drugs covered by this patent

Patent Metadata

Patent number
CN103228280B
Jurisdiction
CN
Classification
—
Expires
2015-11-25
Drug substance claim
No
Drug product claim
No
Assignee
Liu Hanyangxing
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.